Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Ana Marija Slišković

43986

Ana Marija

Slišković

-399725

nije evidentirano
Naziv Akcije
(HRZZ-UIP-2020-02-8189) Šimičević, Livija ; Slišković, Ana Marija ; Vrkić Kirhmajer, Majda ; Ganoci Lana ; Holik, Hrvoje ; Palić, Jozefina ; Samardžić, Jure ; Božina, Tamara Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series // Pharmacy (Basel), 11 (2023), 1; 29, 19. doi: 10.3390/pharmacy11010029
Slišković, Ana Marija ; Rešković Lukšić, Vlatka, Jakšić Jurinjak, Sandra ; Brestovac, Marija ; Palić, Jozefina ; Lovrić Benčić, Martina ; Šeparović Hanževački, jadranka Natural history of tricuspid regurgitation and correlation with right ventricular function. // Cardiologia Croatica, 18 (2023), 5-6; 107-109. doi: 10.15836/ccar2023.107
Strikić, Dominik ; Slišković, Ana Marija ; Vujević, Andro ; Sopek-Merkaš, Ivana ; Merćep, Iveta New prospects in treatment of dyslipidaemia – putting patient compliance first. Medicinska naklada, 2022. str. 279-279 doi: 10.15836/ccar2022.279
Slišković, Ana Marija ; Šimičević, Livija ; Vrkić Kirhmajer, Majda ; Ganoci, Lana ; Holik, Hrvoje ; Samardžić, Jure ; Božina, Tamara Krvarenja povezana s primjenom rivaroksabana - moguća uloga farmakogenetike kao rizičnog čimbenika // 3. hrvatski kongres KLINIČKE FARMACIJE Klinička farmacija u sustavu zdravstva: MOGUĆNOSTI I IZAZOVI Zagreb, Hrvatska, 09.06.2022-11.06.2022
Lakušić, Nenad ; Merkaš, Ivana Sopek ; Slišković, Ana Marija ; Cerovec, Dora Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co- transporter 2 inhibitors // World journal of cardiology, 14 (2022), 10; 561-564. doi: 10.4330/wjc.v14.i10.561
Huljev Frković, Sanda ; Slišković, Ana Marija ; Toivonen, Mia ; Crkvenac Gregorek, Andrea ; Šutalo, Ana ; Vrkić Kirhmajer, Majda Vascular Ehlers-Danlos syndrome, an often unrecognized clinical entity: a case report of a novel mutation in the COL3A1 gene // Croatian medical journal, 63 (2022), 394-398. doi: 10.3325/cmj.2022.63.394
Pavić, Predrag ; Meštrović, Tomislav ; Brižić, Ivan ; Vrkić Kirhmajer, Majda ; Slišković, Ana Marija ; Perkov, Dražen ; Premužić Meštrović, Ivica ; Figl, Josip ; Crkvenac Gregorek, Andrea A rare case of median nerve intraneural hematoma after stenting of right iliac artery: a case report // Medicina Fluminensis, 58 (2022), 2; 171-176. doi: 10.21860/medflum2022_275140
Merćep, Iveta ; Strikić, Dominik ; Slišković, Ana Marija ; Reiner, Željko New Therapeutic Approaches in Treatment of Dyslipidaemia—A Narrative Review // Pharmaceuticals, 15 (2022), 7; 839, 13. doi: 10.3390/ph15070839
Slišković, Ana Marija ; Šimičević, Livija ; Vrkić Kirhmajer, Majda ; Ganoci, Lana ; Holik, Hrvoje ; Samardžić, Jure ; Božina, Tamara The risk factors for bleeding events in patients taking rivaroxaban – possible role of pharmacogenetics // 20th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2022) Prag, Češka Republika, 18.09.2022-21.09.2022
Šimičević, Livija ; Slišković, Ana Marija ; Vrkić Kirhmajer, Majda ; Ganoci, Lana ; Holik, Hrvoje ; Samardžić, Jure ; Božina, Tamara The role of pharmacogenetics as possible risk factor for rivaroxaban - associated bleeding // Pharmaca. 2022. str. 141-141
nije evidentirano
nije evidentirano